King's Health Partners Teams with IDBS on Personalized Cancer Therapy Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS said today it will be providing its Oncology Research Information System translational medicine platform for the Integrated Cancer Centre at King's Health Partners.

The deal, the UK data management and analytics solutions firm said, is the first step in a five-year relationship that may eventually include all disease areas including cancer disorders and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.